Your browser doesn't support javascript.
loading
Performance of a Claims-Based Frailty Proxy Using Varying Frailty Ascertainment Lookback Windows.
Duchesneau, Emilie D; Stürmer, Til; Kim, Dae Hyun; Reeder-Hayes, Katherine; Edwards, Jessie K; Faurot, Keturah R; Lund, Jennifer L.
Afiliación
  • Duchesneau ED; Department of Epidemiology and Prevention, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC.
  • Stürmer T; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Kim DH; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Reeder-Hayes K; Marcus Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Roslindale, MA.
  • Edwards JK; Department of Medicine, Division of Gerontology, Beth Israel Deaconess Medical Center, Brookline, MA.
  • Faurot KR; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Lund JL; Department of Medicine, Division of Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Med Care ; 62(5): 305-313, 2024 May 01.
Article en En | MEDLINE | ID: mdl-38498870
ABSTRACT

BACKGROUND:

Frailty is an aging-related syndrome of reduced physiological reserve to maintain homeostasis. The Faurot frailty index has been validated as a Medicare claims-based proxy for predicting frailty using billing information from a user-specified ascertainment window.

OBJECTIVES:

We assessed the validity of the Faurot frailty index as a predictor of the frailty phenotype and 1-year mortality using varying frailty ascertainment windows. RESEARCH

DESIGN:

We identified older adults (66+ y) in Round 5 (2015) of the National Health and Aging Trends Study with Medicare claims linkage. Gold standard frailty was assessed using the frailty phenotype. We calculated the Faurot frailty index using 3, 6, 8, and 12 months of claims prior to the survey or all-available lookback. Model performance for each window in predicting the frailty phenotype was assessed by quantifying calibration and discrimination. Predictive performance for 1-year mortality was assessed by estimating risk differences across claims-based frailty strata.

RESULTS:

Among 4253 older adults, the 6 and 8-month windows had the best frailty phenotype calibration (calibration slopes 0.88 and 0.87). All-available lookback had the best discrimination (C-statistic=0.780), but poor calibration. Mortality associations were strongest using a 3-month window and monotonically decreased with longer windows. Subgroup analyses revealed worse performance in Black and Hispanic individuals than counterparts.

CONCLUSIONS:

The optimal ascertainment window for the Faurot frailty index may depend on the clinical context, and researchers should consider tradeoffs between discrimination, calibration, and mortality. Sensitivity analyses using different durations can enhance the robustness of inferences. Research is needed to improve prediction across racial and ethnic groups.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fragilidad Límite: Aged / Humans País/Región como asunto: America do norte Idioma: En Revista: Med Care Año: 2024 Tipo del documento: Article País de afiliación: Nueva Caledonia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fragilidad Límite: Aged / Humans País/Región como asunto: America do norte Idioma: En Revista: Med Care Año: 2024 Tipo del documento: Article País de afiliación: Nueva Caledonia